Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials

References

Page 1

	Year	Citations
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Peter G. Pappas, Carol A. Kauffman, David R. Andes, Clinical Infectious Diseases	2015	3.9K
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients Oliver A. Cornely, Matteo Bassetti, Thierry Calandra, Clinical Microbiology and Infection Diagnostic MycologyTranslational MedicineNon-neutropenic Adult PatientsVaginitisCandida Diseases 2012	2012	1.2K
Anidulafungin versus Fluconazole for Invasive Candidiasis Annette C. Reboli, Coleman Rotstein, Peter G. Pappas, New England Journal of Medicine	2007	888
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials David R. Andes, Nasia Safdar, John W. Baddley, Clinical Infectious Diseases	2012	788
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model Bennett Vogelman, J. E. Leggett, John Turnidge, The Journal of Infectious Diseases	1988	713
Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis Peter G. Pappas, C. M. F. Rotstein, Robert F. Betts, Clinical Infectious Diseases	2007	628
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project Matteo Bassetti, Daniele Roberto Giacobbe, Antonio Vena, Critical Care	2019	227
Burden of Candidemia in the United States, 2017 Sharon Tsay, Yi Mu, Sabrina Williams, Clinical Infectious Diseases	2020	152
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial George R. Thompson, Àlex Soriano, Oliver A. Cornely, The Lancet Translational MedicineAntifungal AgentAntifungal AgentsRezafungin Versus CaspofunginRandomised Phase 3	2022	150
Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults Taylor Sandison, Voon Ong, Jonathan Lee, Antimicrobial Agents and Chemotherapy	2016	149

Page 1